The BA.5 omicron subvariant, which is now the most prevalent coronavirus strain in the United States, is four times more resistant to COVID-19 vaccines, according to a new study.
Executives have said they hope the shot will see uptake in individuals who have expressed hesitancy toward other COVID-19 vaccines or are allergic to components of the others' ingredients.
The number of monkeypox vaccine doses distributed across the United States has more than tripled since last week, according to HHS, but supply falls far short of demand – and short of the levels that experts say will be needed to control the outbreak.
Increasingly, more people appear to be contracting the virus multiple times in relatively quick succession, as another omicron subvariant sweeps through the U.S.